COOPERATIVE PROTOCOL RESEARCH PROGRAMS RECOGNIZED BY OPRR

(Revised 6/6/00)

A. Research supported by the National Cancer Institute (NCI) which is subject to review by a Protocol Review Committee of the Division of Cancer Treatment and Diagnosis (DCTD) as listed below:

  1. All oncology protocols from NCI-funded or unfunded Cooperative Groups, Consortia, or Networks, such as, but not limited to the following;

      ACSOG American College of Surgeons Oncology Group
      ACRIN American College of Radiology Imaging Network
      AMC AIDS Malignancy Consortium
      CALGB Cancer and Leukemia Group B
      CCG Children's Cancer Group
      ECOG Eastern Cooperative Oncology Group
      EPP Expanded Participation Project
      GOG Gynecologic Oncology Group
      IRS Intergroup Rhabdomyosarcoma Study
      NABTC North American Brain Tumor Consortium
      NABTT New Approaches to Brain Tumor Therapy Consortium
      NCIC National Cancer Institute of Canada
      NCTTG North Central Cancer Treatment Group
      NSABP National Surgical Adjuvant Project for Breast and Bowel Cancers
      NWTSG National Wilms Tumor Study Group
      POG Pediatric Oncology Group
      PROG Proton Radiation Oncology Group
      RDOG Radiological Diagnostic Oncology Group
      RTOG Radiation Therapy Oncology Group
      SWOG Southwest Oncology Group

  2. All NCI-funded Community Clinical Oncology Program (CCOP) protocols using NCI-sponsored or supplied IND agents.

  3.Protocols using either NCI-sponsored IND agents or NCI-supplied agents such as by NCI-designated Cancer Centers (CACTRs), including their affiliated entities.

  4.International Collaborations with NCI Cooperative Oncology Groups and/or IND agents supplied by NCI by holders of OPRR-approved International Cooperative Project Assurances (ICPAs), for example EORTC (a complete list of all OPRR-approved ICPAs is maintained at  http://www.hhs.gov/ohrp/humansubjects/assurance/icpa.htm.


B. Research supported by the National Institute of Allergy and Infectious Diseases (NIAID) which is subject to review by a Protocol Review Committee of the Division of AIDS (DAIDS) or the Division of Microbiology and Infectious Diseases (DMID) as below:

  1. All Community Programs for Clinical Research on AIDS (CPCRA) protocols.

  2. All AIDS Clinical Trials Group (ACTG) protocols.

  3. All DAIDS Treatment Research Initiative (DATRI) protocols.

  4. All Collaborative Antiviral Study Group (CASG) protocols of DMID.

  5. All Mycoses Study Group (MSG) protocols of DMID.

  6. Malaria Research Program (MRP) protocols of DMID.

  7. IL-2 Trials Group (IL2) protocols of DMID (includes ESPRIT).

  8. HIV Prevention Trials Network (HPTN).

  9. HIV Vaccine Trials Network (HVTN).


C. Research supported by the Centers for Disease Control and Prevention (CDC) which is subject to review by the Deputy Associate Director for Science in the Office of the Director, CDC, as listed below:

  1. International CPRP for Collaborative Partnerships with Foreign Nations (ICPRP)

  2. TB Trials Consortium (TBTC)


D. Research supported by the National Institute on Drug Abuse (NIDA) which is subject to review by the NIDA Protocol Review Board as listed below:

  1. National Drug Abuse Treatment Clinical Trials Network (CTN)



This list of OHRP-recognized CPRP programs may be modified by OHRP as appropriate by OHRP. Institutions with OHRP-approved CPAs are found at http://ohrp.cit.nih.gov/search/asearch.asp.  General inquires concerning management of CPRPs and CPAs may be directed to Ms. Helen Gordon at 301-402-5709 or hgordon@osophs.dhhs.gov. Assistance in the management of specific CPRP protocol or research planning issues is also be available from assigned OHRP staff. These assignments are posted at   http://www.hhs.gov/ohrp/daqi-staff.htm#Table2.


If you have questions about human subject research, click   ohrp@osophs.dhhs.gov
If you have questions/suggestions about this web page, click  Webmaster
Updated April 17, 2003